Contact investigations for outbreaks of Mycobacterium tuberculosis: Advances through whole genome sequencing

Clinical Microbiology and Infection

Volumn 19, Issue 9, 2013, Pages 796-802

  Walker, T M ^a   Monk, P ^b   Smith, E Grace ^c   Peto, T E A ^a,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Contact investigation; Outbreak; Tuberculosis; Whole genome sequencing

Indexed keywords

BACTERIAL GENOME; GENE SEQUENCE; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MASS RADIOGRAPHY; MOLECULAR CLOCK; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYLOGENETIC TREE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; TUBERCULOSIS CONTROL; VARIABLE NUMBER OF TANDEM REPEAT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84882707290     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12183     Document Type: Review

References (46)

1. Lienhardt C, Glaziou P, Uplekar M, Lönnroth K, Getahun H, Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol 2012; 10: 407-416.
2. Davies PDO, Grange JM. Factors affecting susceptibility and resistance to tuberculosis. Thorax 2001; 56(suppl 2): ii23-ii29.
3. Hershberg RR, Lipatov MM, Small PMP et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol 2008; 6: 2658-2671.
4. Arnold D. Colonizing the body: state medicine and epidemic disease in nineteenth-century India. Berkeley and Los Angeles, California: University of California Press, 1993.
5. Young DB, Perkins MD, Duncan K, Barry CE III. Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest 2008; 118: 1255-1265.
6. Raviglione M, Marais B, Floyd K et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet 2012; 379: 1902-1913.
7. Koch R. The Nobel Lecture on how the fight against tuberculosis now stands. Lancet 1906; 167: 1449-1451.
8. Tuberculosis in the UK: 2012 report. Available from: http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1317134916916
9. Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8: 359-368.
10. Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2005; 361: 1168-1173.
11. Gardy JL, Johnston JC, Sui SJH et al. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 2011; 364: 730-739.
12. Valway SE, Sanchez MP, Shinnick TF et al. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med 1998; 338: 633-639.
13. Curtis ABA, Ridzon RR, Vogel RR et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med 1999; 341: 1491-1495.
14. Riley RL, Mills CC, Nyka W et al. Aerial dissemination of pulmonary tuberculosis. a two-year study of contagion in a tuberculosis ward. Am J Hyg 1959; 70: 185-196.
15. Escombe AR, Moore DAJ, Gilman RH et al. The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med 2008; 5: 1387-1397.
16. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature 2005; 438: 355-359.
17. Golub JE, Mohan CI, Comstock GW, Chaisson RE. Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis 2005; 9: 1183-1203.
18. Burki T. Tackling tuberculosis in London's homeless population. Lancet 2010; 376: 2055-2056.
19. Bothamley GH, Ditiu L, Migliori GB, Lange C, TBNET contributors. Active case finding of tuberculosis in Europe: a Tuberculosis Network European Trials Group (TBNET) survey. Eur Respir J 2008; 32: 1023-1030.
20. National Tuberculosis Controllers Association, Centers for Disease Control and Prevention (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep 2005; 54(RR15): 1-37.
21. Cook VJ, Shah L, Gardy J, Bourgeois A-C. Recommendations on modern contact investigation methods for enhancing tuberculosis control. Int J Tuberc Lung Dis 2011; 16: 297-305.
22. Tardin A, Dominicé Dao M, Ninet B, Janssens JP. Tuberculosis cluster in an immigrant community: case identification issues and a transcultural perspective. Tropical Med Int Health 2009; 14: 995-1002.
23. Asghar RJ, Patlan DE, Miner MC et al. Limited utility of name-based tuberculosis contact investigations among persons using illicit drugs: results of an outbreak investigation. J Urban Health 2009; 86: 776-780.
24. Schürch AC, van Soolingen D. DNA fingerprinting of Mycobacterium tuberculosis: from phage typing to whole-genome sequencing. Infect Genet Evol 2011; 12: 602-609.
25. Mazars E, Lesjean S, Banuls AL et al. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci USA 2001; 98: 1901-1906.
26. Oelemann MC, Diel R, Vatin V et al. Assessment of an optimized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis. J Clin Microbiol 2007; 45: 691-697.
27. Allix-Beguec C, Harmsen D, Weniger T, Supply P, Niemann S. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2008; 46: 2692-2699.
28. Allix-Beguec C, Fauville-Dufaux M, Supply P. Three-year population-based evaluation of standardized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2008; 46: 1398-1406.
29. Hawkey PM, Smith EG, Evans JT et al. Mycobacterial interspersed repetitive unit typing of Mycobacterium tuberculosis compared to IS6110-based restriction fragment length polymorphism analysis for investigation of apparently clustered cases of tuberculosis. J Clin Microbiol 2003; 41: 3514-3520.
30. Walker TM, Ip CL, Harrell RH et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 2013; 13: 137-146.
31. Al-Hajoj SAM, Akkerman O, Parwati I et al. Microevolution of Mycobacterium tuberculosis in a tuberculosis patient. J Clin Microbiol 2010; 48: 3813-3816.
32. Pérez-Lago L, Herranz M, Lirola MM, INDAL-TB Group, Bouza E, García de Viedma D. Characterization of microevolution events in Mycobacterium tuberculosis strains involved in recent transmission clusters. J Clin Microbiol 2011; 49: 3771-3776.
33. Didelot X, Bowden R, Wilson DJ, Peto TEA, Crook DW. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet 2012; 13: 601-612.
34. Underwood A, Green J. Call for a quality standard for sequence-based assays in clinical microbiology: necessity for quality assessment of sequences used in microbial identification and typing. J Clin Microbiol 2011; 49: 23-26.
35. Chan JZM, Pallen MJ, Oppenheim B, Constantinidou C. Genome sequencing in clinical microbiology. Nat Biotechnol 2012; 11: 1068-1071.
36. Ford CB, Lin PL, Chase MR et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet 2011; 43: 482-486.
37. Namouchi A, Didelot X, Schock U, Gicquel B, Rocha EPC. After the bottleneck: genome-wide diversification of the Mycobacterium tuberculosis complex by mutation, recombination, and natural selection. Genome Res 2012; 22: 721-734.
38. Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci USA 2004; 101: 4871-4876.
39. Liu X, Gutacker MM, Musser JM, Fu YX. Evidence for recombination in Mycobacterium tuberculosis. J Bacteriol 2006; 188: 8169-8177.
40. Casali N, Nikolayevskyy V, Balabanova Y et al. Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Res 2012; 22: 735-745.
41. Schurch AC, Kremer K, Daviena O et al. High-resolution typing by integration of genome sequencing data in a large tuberculosis cluster. J Clin Microbiol 2010; 48: 3403-3406.
42. Borgdorff MW, van den Hof S, Kalisvaart N, Kremer K, van Soolingen D. Influence of sampling on clustering and associations with risk factors in the molecular epidemiology of tuberculosis. Am J Epidemiol 2011; 174: 243-251.
43. Zumla A, Abubakar I, Raviglione M et al. Drug-resistant tuberculosis-current dilemmas, unanswered questions, challenges, and priority needs. J Infect Dis 2012; 205(suppl 2): S228-S240.
44. Lawn SD, Brooks SV, Kranzer K et al. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011; 8: 1-11.
45. Eisenstein M. The battle for sequencing supremacy. Nat Biotechnol 2012; 30: 1023-1026.
46. Daum LT, Rodriguez JD, Worthy SA et al. Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains. J Clin Microbiol 2012; 50: 3831-3837.